23 Nov Multiple Sclerosis
Multiple sclerosis (MS) is a chronic, inflammatory, and degenerative neurological illness with no cure. It has been suggested that Hyperbaric Oxygen Therapy (HBO(2)T) may slow or reverse the progress of the disease.
Over the past two decades, extensive international medical research has demonstrated that HBO can play an extremely important role in the treatment of multiple sclerosis (MS). In many European countries, HBO is now considered an integral part of the MS treatment program – in England alone, over 10,000 MS patients are currently receiving hyperbaric oxygen treatment.
In a recent publication in the prestigious New England Journal of Medicine entitled, “Hyperbaric Oxygen Treatment of Multiple Sclerosis, a Randomized, Placebo Controlled, Double-blind Study,” researchers demonstrated significant objective improvements in a variety of MS symptoms in 70% of patients treated. At one year after treatment, deterioration was noted in 55% of MS patients not treated as compared to only 12% of patients who underwent hyperbaric oxygen treatment.